Miura Hiromi, Imafuku Jurai, Kurosaki Aki, Sato Masahiro, Ma Yongjie, Zhang Guisheng, Mizutani Akiko, Kamimura Kenya, Gurumurthy Channabasavaiah B, Liu Dexi, Ohtsuka Masato
Department of Molecular Life Science, Division of Basic Medical Science and Molecular Medicine, Tokai University School of Medicine, Kanagawa, Japan.
Center for Matrix Biology and Medicine, Graduate School of Medicine, Tokai University, Kanagawa, Japan.
Mol Ther Nucleic Acids. 2021 Mar 5;24:325-336. doi: 10.1016/j.omtn.2021.03.003. eCollection 2021 Jun 4.
The clustered regularly interspersed palindromic repeats (CRISPR) system is a powerful genome-editing tool to modify genomes, virtually in any species. The CRISPR tool has now been utilized in many areas of medical research, including gene therapy. Although several proof-of-concept studies show the feasibility of gene therapy applications for correcting disease-causing mutations, and new and improved tools are constantly being developed, there are not many choices of suitable reporter models to evaluate genome editor tools and their delivery methods. Here, we developed and validated reporter mouse models containing a single copy of disrupted (ΔEGFP) via frameshift mutations. We tested several delivery methods for validation of the reporters, and we demonstrated their utility to assess both non-homologous end-joining (NHEJ) and via homology-directed repair (HDR) processes in embryos and in somatic tissues. With the use of the reporters, we also show that hydrodynamic delivery of ribonucleoprotein (RNP) with (Sp)Cas9 protein mixed with synthetic guide RNA (gRNA) elicits better genome-editing efficiencies than the plasmid vector-based system in mouse liver. The reporters can also be used for assessing HDR efficiencies of the (As)Cas12a nuclease. The results suggest that the ΔEGFP mouse models serve as valuable tools for evaluation of genome editing.
成簇规律间隔短回文重复序列(CRISPR)系统是一种强大的基因组编辑工具,几乎可用于修饰任何物种的基因组。CRISPR工具现已应用于医学研究的许多领域,包括基因治疗。尽管多项概念验证研究表明了基因治疗应用于纠正致病突变的可行性,并且新的和改良的工具也在不断开发,但用于评估基因组编辑工具及其递送方法的合适报告模型选择并不多。在此,我们开发并验证了通过移码突变包含单个破坏拷贝(ΔEGFP)的报告基因小鼠模型。我们测试了几种递送方法以验证报告基因,并证明了它们在评估胚胎和体细胞组织中的非同源末端连接(NHEJ)和同源定向修复(HDR)过程方面的效用。通过使用这些报告基因,我们还表明,将核糖核蛋白(RNP)与(Sp)Cas9蛋白和合成引导RNA(gRNA)混合进行流体动力学递送,在小鼠肝脏中比基于质粒载体的系统能引发更高的基因组编辑效率。这些报告基因还可用于评估(As)Cas12a核酸酶的HDR效率。结果表明,ΔEGFP小鼠模型是评估基因组编辑的有价值工具。